Case File
efta-efta00759448DOJ Data Set 9OtherFrom: Jeffrey M Matusow
Date
Unknown
Source
DOJ Data Set 9
Reference
efta-efta00759448
Pages
2
Persons
0
Integrity
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
From: Jeffrey M Matusow
To: Jeffrey Epstein <[email protected]>
Cc: Thomas McGraw .y
Subject: RE: CIT's Bonds Gain After S&P Assigns Lender Junk Debt Ranking
Date: Fri, 30 Apr 2010 13:05:14 +0000
Jeffrey M. Matusow
JPMorgan Private Bank 140 West 57th Street, 33rd Floor, New York, NY 10019
Work
Email:
IRS Circular 230 Disclosure:
JPMorgan Chase & Co. and its affiliates do not provide tax advice. Accordingly, any discussion of U.S. tax matters contained herein
(including any attachments) is not intended or written to be used, and cannot be used, in connection with the promotion, marketing
or recommendation by anyone unaffiliated with JPMorgan Chase & Co. of any of the matters addressed herein or for the purpose of
avoiding U.S. tax-related penalties.
From: Jeffrey Epstein [mailto:[email protected]]
Sent: Friday, April 30, 2010 9:03 AM
To: Jeffrey M Matusow
Subject: Re: CIT's Bonds Gain After S&P Assigns Lender Junk Debt Ranking
email me mcgraws number please
On Thu, Apr 29, 2010 at 5:38 PM, Jeffrey M Matusow
As we expected, CIT was assigned a rating by S+P today - B+/B.
The bonds rallied 1.5 points on the news.
Jeff
CIT's Bonds Gain After S&P Assigns Lender Junk Debt Ranking
2010-04-29 20:41:37.969 GMT
By Pierre Paulden and David Henry
April 29 (Bloomberg) -- CIT Group Inc. bonds rose after
Standard & Poor's assigned the commercial lender a high-yield,
high-risk rating four months after it emerged from bankruptcy.
> wrote:
EFTA00759448
S&P assigned its B+/B ranking citing "the considerable
transitional challenges CIT faces in transforming its funding
platform," New York-based analysts Rian Pressman and Jeffrey
Zaun wrote today in a report. S&P rated the company's unsecured
debt B, five steps below investment grade.
CIT securities have surged since the New York-based company
emerged from bankruptcy in December, indicating bond investors
believe the lender run by John Thain will be able to refinance
its debt at lower costs. The lender reported a first-quarter
profit of $97 million, or 49 cents a share, beating the average
projection of four analysts surveyed by Bloomberg for a loss of
25 cents a share.
CIT's $7.36 billion of 7 percent notes due 2017 rose 1.5
cents on the dollar to 94.75 cents as of 4:34 p.m. in New York,
according to Trace, the bond-price reporting system of the
Financial Industry Regulatory Authority. The bonds traded as
high as 95.75 cents earlier in the afternoon.
The bonds have climbed from 85 cents on Dec. 9, before CIT
exited Chapter 11 protection, rewarding creditors from Loomis
Sayles & Co. to Pacific Investment Management Co.
CIT filed for bankruptcy in November after posting nine
quarters of losses totaling more than $5 billion. The company
emerged from court protection after cutting $10.4 billion of
debt and delaying maturities by at least three years, with a
plan to operate more businesses through banking units so they
can tap financing from lower-cost deposits backed by the Federal
Deposit Insurance Corp.
This email is confidential and subject to important disclaimers and
conditions including on offers for the purchase or sale of
securities, accuracy and completeness of information, viruses,
confidentiality, legal privilege, and legal entity disclaimers,
available at http://www.jpmorgan.com/pages/disclosures/email.
The information contained in this communication is
confidential, may be attorney-client privileged, may
constitute inside information, and is intended only for
the use of the addressee. It is the property of
Jeffrey Epstein
Unauthorized use, disclosure or copying of this
communication or any part thereof is strictly prohibited
and may be unlawful. If you have received this
communication in error, please notify us immediately by
return e-mail or by e-mail to [email protected], and
destroy this communication and all copies thereof,
including all attachments.
EFTA00759449
Technical Artifacts (4)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
Email
[email protected]Email
[email protected]URL
http://www.jpmorgan.com/pages/disclosures/emailWire Ref
refinanceRelated Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 11OtherUnknown
EFTA02367961
1p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.